政府事务顾问（6个月合同）
Government Affairs Consultant (6-month contract)
政府事务顾问（德国）
6个月合同 | 兼职咨询（每周2-3天）
地点：德国。柏林优先；巴登-符腾堡州、巴伐利亚州、北莱茵-威斯特法伦州也合适。预计定期前往柏林、波恩以及选定的大学医院/政策中心。
我们寻找的人选
Oxford Nanopore 正在寻求一位经验丰富的政府事务顾问，以兼职咨询方式领导我们在德国的政策参与和利益相关者战略。这是一次独特的机会，为一位与政府关系广泛的医疗政策专业人士提供帮助，塑造创新基因组技术在一个欧洲最具影响力的医疗市场中的应用环境。
成功的顾问将具备对德国医疗保健和政策制定环境的深入了解，能够可信地与政府、自治机构、临床网络、患者组织和行业协会进行沟通。与我们的全球及EMEA政府事务团队密切合作，您将帮助将 Oxford Nanopore 定位为基因组医学、健康数据基础设施和未来报销路径发展中的可信赖合作伙伴。
我们特别关注那些了解医疗政策、诊断、基因组学和创新交叉点的人员，并且有动力支持下一代测序技术在罕见病、肿瘤学和病原体基因组学中的临床实践整合。
主要职责
- 策略与定位：制定德国政府事务计划和纳米孔测序在基因组医学、健康数据基础设施、报销和准备方面的政策叙述。
- 利益相关者互动：与联邦政府、自治机构、各州、行业协会、临床网络和患者利益相关者建立合规关系，包括 BfArM/genomDE/MV GenomSeq、G-BA/IQWiG 和 VDGH。
- 政策情报：监控 § 64e SGB V、genomDE、GDNG/FDZ Gesundheit、EHDS、IVDR、ePA 和报销进展；总结影响、风险和机会。
- 证据与准入：支持市场准入、医学/临床事务、监管和技术团队，解决罕见病、肿瘤学和病原体基因组学中的证据缺口、验证要求和政策障碍。
- 外部代表：支持既定的政策论坛、协会工作、利益相关者简报、会议摘要、圆桌会议、咨询输入和立场文件。
查看英文原文
Government Affairs Consultant (Germany)
6-Month Contract | Part-Time Consultancy (2-3 Days Per Week)
Location: Germany. Berlin preferred; Baden-Württemberg, Bavaria, North Rhine-Westphalia also suitable. Regular travel to Berlin, Bonn and selected university-hospital/policy hubs expected.
What We're Seeking
Oxford Nanopore is seeking an experienced Government Affairs Consultant to lead our policy engagement and stakeholder strategy in Germany on a part-time consultancy basis. This is a unique opportunity for a well-connected health policy professional to help shape the environment for the adoption of innovative genomic technologies within one of Europe's most influential healthcare markets.
The successful consultant will bring deep knowledge of the German healthcare and policymaking landscape, with the ability to engage credibly across government, self-governance bodies, clinical networks, patient organisations and industry associations. Working closely with our Global and EMEA Government Affairs teams, you will help position Oxford Nanopore as a trusted partner in the development of genomic medicine, health-data infrastructure and future reimbursement pathways.
We are particularly interested in individuals who understand the intersection of healthcare policy, diagnostics, genomics and innovation, and who are motivated by the opportunity to support the integration of next-generation sequencing technologies into clinical practice across rare disease, oncology and pathogen genomics.
Key Responsibilities
- Strategy and positioning: Develop the Germany government affairs plan and policy narrative for nanopore sequencing in genomic medicine, health-data infrastructure, reimbursement and preparedness.
- Stakeholder engagement: Build compliant relationships with priority federal, self-governance, Länder, trade-association, clinical-network and patient stakeholders, including BfArM/genomDE/MV GenomSeq, G-BA/IQWiG and VDGH.
- Policy intelligence: Monitor § 64e SGB V, genomDE, GDNG/FDZ Gesundheit, EHDS, IVDR, ePA and reimbursement developments; summarise implications, risks and opportunities.
- Evidence and access: Support Market Access, Medical/Clinical Affairs, Regulatory and technical teams on evidence gaps, validation requirements and policy barriers in rare disease, oncology and pathogen genomics.
- External representation: Support agreed policy forums, association work, stakeholder briefs, meeting readouts, roundtables, consultation inputs and position papers, in conjunction with central Government Affairs team.
- Compliance and reporting: Maintain stakeholder maps, engagement trackers and monthly intelligence notes; ensure activities follow Oxford Nanopore policies, German transparency requirements and Legal/Compliance review.
Experience:
Essential
· Native or fluent German speaker with strong English
- Significant experience in German health policy/government affairs
- Strong understanding of Germany’s healthcare system, including federal/Länder structure and key decision-making bodies
- Proven ability to credibly engage with public institutions, clinicians, and scientific stakeholders
Desirable
· Experience in genomics, diagnostics, or precision medicine
- Familiarity with key frameworks (e.g. §64e SGB V, G-BA/IQWiG processes, genomDE, EHDS)
- Existing network across government, policy and to some extent university hospitals, research institutes, or relevant agencies
- Understanding of the wider EU policy landscape and the role of Brussels
Success Measures
- Evidence of ONT engagement within key policy and government stakeholders
- Development of a credible German political stakeholder network supporting ONT use cases
- Contribution to positioning ONT as a trusted partner in German genomics infrastructure
Why This Role Matters
Germany is an institution-led market where clinical adoption depends on validation, governance, and reimbursement systems rather than commercial access alone. This role is therefore critical to ensuring ONT is embedded within the structures that define long-term clinical scale.
Please note that no terminology in this advert is intended to discriminate on the grounds of a person's gender, marital status, race, religion, colour, age, disability or sexual orientation. Every candidate will be assessed only in accordance with their merits, qualifications and abilities to perform the duties of the job.
Originally posted on Himalayas